Ionis Pharmaceuticals 10K 2005 Annual report | IONS Filing

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	8th grade Good

New words: abreast, Achaogen, ADA, aggressive, airway, ALS, ALSA, amenable, aminoglycoside, amyotrophic, analytical, argument, artery, assemble, assembling, attack, Attending, augment, Avenue, avian, bacterial, begun, beneath, beneficiary, bifurcated, Bioforensic, BioMed, biowarfare, birth, Black, brand, budget, budgetary, cancerinflammatory, capsule, carcinoma, cerebral, CNS, commensurate, condensed, confer, consecutive, cornea, coronary, CRP, cycle, DC, deadline, debarment, deducting, depletion, deterrence, device, DHS, diminish, disaster, dismutase, displace, dissolved, divert, DME, dominance, dominantly, drawdown, drew, earliest, easy, edema, Electric, electronically, enemacream, enjoy, error, exemplify, expend, ezetimibe, fall, FAS, FH, field, fifteen, fingerprint, flu, fluid, foot, forecast, forensic, FSP, fungal, Green, guide, hardware, heard, heat, HeFH, hepatocellular, HoFH, homeland, hope, hyper, hypercholesterolemia, ico, ID, identity, ill, impossible, impracticable, inclusion, infrastructure, inherited, injury, Intensivist, interleukin, intrathecal, itsr, Justice, Klein, lapsed, larger, leakage, led, lengthen, lengthy, lethal, liable, licensee, lipid, Ludwig, lymphatic, markedly, meaningful, mechanistic, Medline, metastatic, micro, Microorganism, microscopy, middle, monitor, monotherapy, morbidity, mouse, multiplexed, Naval, NE, neurodegenerative, Neurologic, Neurological, newly, nosocomial, obigonucleotide, ophthalmology, OSI, outlined, outsmart, owner, parallel, pathway, PCR, penalty, pinpoint, PMA, pneumonia, policy, precise, premarket, premature, prescription, principle, proceeding, promoted, puberty, quantification, question, quickly, Realty, relevant, renew, rentable, repeated, replace, replacement, reputation, resale, resolve, revaluation, revalued, revolutionary, Room, Rosetta, saving, seasoned, serum, shell, shock, simple, simvastatin, spectrum, spinal, spread, spreading, STANELY, statutory, Stone, strain, Street, submission, substance, superoxide, surgery, suspended, suspension, timeframe, track, training, transgenic, treasury, twenty, unaware, uncharacterized, unidentified, urinary, viability, Virtually, vulnerable, Washington, waxy, website, wedel

Removed: accreting, adhesion, adjunct, analyzing, annually, antibacterial, Automation, awarded, Axon, bore, borrow, bring, brown, Canadian, Chiron, CIBA, cidofovir, Citicorp, composition, conclusion, construction, custom, Deed, developer, digestive, EPIX, evaluated, extinguishment, fever, fomivirsen, foscarnet, ganciclovir, gastrointestinal, genetrove, hair, HIV, imaging, immune, Imperial, implicated, infrequently, innermost, integral, interbanking, intercellular, Irori, lend, Lowenstam, magnetic, Manager, McNeil, measure, mentioned, nonstatutory, North, oligomeric, oncology, planned, platform, PositionStanley, prepay, prioritize, processing, professor, Quotron, reacquired, release, repay, repayable, resonance, rheumatoid, skaletsky, slightly, susceptible, taxotere, throughput, unamortized, unculturable, vision, web

Ionis Pharmaceuticals (IONS) 10-K2005 FY Annual report

Content analysis